Position in ROIV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,986,000
-$8,623,415 QoQ
Shares Held
180,000
-71.3% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Prosight Management, LP holds $415,390,745 across 22 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LKFT |
Lakefront Biotherapeutics NV
|
2,043,344 | $61,259,453 | |
| 2 | JANX |
Janux Therapeutics, Inc.
|
3,804,481 | $58,436,828 | |
| 3 | NKTR |
Nektar Therapeutics
|
810,000 | $56,546,100 | |
| 4 | STTK |
Shattuck Labs, Inc.
|
5,957,877 | $41,347,666 | |
| 5 | INSM |
INSMED Inc
|
375,609 | $40,047,431 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
98,080 | $29,525,022 | |
| 7 | SNDX |
Syndax Pharmaceuticals Inc
|
1,200,000 | $26,232,000 | |
| 8 | KURA |
Kura Oncology, Inc.
|
2,021,964 | $22,180,945 |
All Filings in ROIV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,986,000 | 180,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,609,415 | 627,162 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,206,115 | 1,335,500 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,382,234 | 1,808,539 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,425,984 | 1,826,163 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $17,745,000 | 1,500,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,866,248 | 1,721,512 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,140,000 | 2,000,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $19,604,400 | 1,860,000 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||